5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver diseaseRecruitingPhase 22026-10-09NCT07288138
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing CholangitisCholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitisRecruitingPhase 32026-10-01NCT07387549
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver diseaseRecruitingNot applicable2026-05-19NCT04054310
Assessment of Non-Invasive Testing in Major Liver-Related Outcomesmetabolic dysfunction-associated steatotic liver diseaseEnrolling by invitationNot stated2026-03-27NCT06986447
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver CirrhoticsAscites, Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorderRecruitingPhase 12025-09-05NCT05490888